Company: ABUS
Filing Date: 2025-10-07
Form Type: 8-K
Source: 0001171843-25-006316
Chunk: 0

Company: Arbutus Biopharma Corp
Filing Date: 2025-10-07
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On October 7, 2025, Arbutus Biopharma Corporation (the “ Company”) issued a press release announcing that three abstracts featuring imdusiran data and one abstract featuring AB-101 data, have been accepted for poster presentations at the American Association for the Study of Liver Diseases - The Liver Meeting® 2025, taking place November 7 - 11, 2025 in Washington, DC. The AB-101 abstract has been selected as a Poster of Distinction. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit Number      Description                                                                  
            99.1      Press Release dated October 7, 2025                                          
 ───────────────────────────────────────────────────────────────────────────────────────────────────
             104      Cover Page Interactive Data File (embedded within the Inline XBRL document)